跳至主要内容
临床试验/NCT02504242
NCT02504242Unknown3 期

A Multi-center, Comparative Clinical Trial to Evaluate the Efficacy and Safety of Inject BMP in Patients Undergoing Transforaminal Lumbar Interbody Fusion

BioAlpha Inc.0 个研究点目标入组 128 人开始时间: 2015年4月1日最近更新:
适应症
干预措施

试验速览

阶段
3 期
发起方
入组人数
128
主要终点
Bone Fusion With CT and Dynamic radiographs(X-ray)(post operative 48 weeks)

研究概览

简要总结

A Randomized, Subject-Assessor Blind, Multi-center, Comparative Clinical Trial to evaluate the efficacy and safety of Inject BMP in Patients Undergoing Transforaminal Lumbar Interbody Fusion.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
19 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •The subject needs the infusion between the first lumbar vertebrato and the first ilium from those who require posterior spinal instrumentation and interbody fusion for the following reasons,
  • •Spinal stenosis
  • •Spinal disc herniation requiring broad laminectomy
  • •Spondylolisthesis or spondylolysis
  • •Recurrent herniated disc

排除标准

  • •Patients with BMD T-score < -3.0
  • •Women who are pregnant or plan to be pregnant within study period

研究组 & 干预措施

Inject BMP

Experimental

ExcelOS Inject / rhBMP-2

干预措施: Inject BMP (Device)

Locally Harvested Bone

Active Comparator

Locally Harvested Bone

干预措施: Locally Harvested Bone (Procedure)

结局指标

主要结局

Bone Fusion With CT and Dynamic radiographs(X-ray)(post operative 48 weeks)

时间窗: at 48 weeks after surgery

次要结局

未报告次要终点

研究者

发起方
BioAlpha Inc.
申办方类型
Industry
责任方
Sponsor

相似试验